Earnings summaries and quarterly performance for Ingevity.
Research analysts who have asked questions during Ingevity earnings calls.
DR
Daniel Rizzo
Jefferies
4 questions for NGVT
Also covers: APD, ATR, AZZ +15 more
John McNulty
BMO Capital Markets
4 questions for NGVT
Also covers: APD, ASH, AVY +14 more
JT
Jonathan Tanwanteng
CJS Securities
3 questions for NGVT
Also covers: APG, ATRO, CMCO +15 more
Abigail Eberts
Wells Fargo
2 questions for NGVT
Also covers: ALB, IFF
Michael Sison
Wells Fargo
2 questions for NGVT
Also covers: ALB, APD, ASH +15 more
LJ
Lee Jagoda
CJS Securities
1 question for NGVT
Also covers: GFF, HLMN, MODV +3 more
Recent press releases and 8-K filings for NGVT.
Ingevity Completes Sale of CTO Refinery Assets and Industrial Specialties Product Line
NGVT
M&A
- Ingevity Corporation announced the successful completion of the sale of its North Charleston Crude Tall Oil (CTO) refinery assets and the majority of its Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC.
- The transaction was completed on January 1, 2026, for an all-cash consideration of $110 million at closing, with potential contingent consideration ranging from $0 to $19 million.
- This sale is a key step in Ingevity's strategy to simplify and streamline its business, focusing on higher-margin specialty applications in activated carbon and pavement technologies, while retaining its Pavement Technologies business and other lignin-based dispersant products.
Jan 5, 2026, 11:39 AM
Ingevity Announces Business Simplification and New Strategic Focus with 2027E Financial Outlook
NGVT
Guidance Update
M&A
New Projects/Investments
- Ingevity is undergoing a business simplification by exiting Industrial Specialties and initiating sales processes for Advanced Polymer Technologies and Road Markings.
- The "New Ingevity" will focus on two core businesses: Performance Materials and Pavement Technologies, aiming for superior and consistent profitability.
- The company projects 2027E Revenue of $940-980 million, EBITDA of $350-370 million, and an EBITDA Margin of 36-39% for the New Ingevity.
- Ingevity expects to generate $200M+ of free cash flow per year in 2026/2027 and targets a Net Debt to Adjusted EBITDA leverage of 2-2.5x.
- The strategy includes leveraging strong cash flow and divestiture proceeds to invest in organic growth, reduce debt, and return significant capital to shareholders.
Dec 8, 2025, 2:00 PM
Ingevity Announces Strategic Portfolio Update and Financial Outlook
NGVT
M&A
Guidance Update
Share Buyback
CFO Change
- Ingevity announced a strategic portfolio transformation, initiating sales processes for its Advanced Polymer Technologies and Road Markings businesses, and is on track to close the sale of Industrial Specialties by early 2026. The company will focus on two core segments: Performance Materials and Pavement Technologies.
- The "new Ingevity" is projected to achieve pro forma revenue of around $900 million with EBITDA margins of approximately 37%. The company anticipates generating nearly $1 billion in deployable cash over the next two years, targeting annual revenue and EBITDA growth over 3%, and annual EPS growth above 10%.
- Capital allocation priorities include fueling organic growth, reducing debt to a target leverage of 2-2.5 times, and returning capital to shareholders, with plans to utilize the remaining $300 million share repurchase authorization over the next two years. M&A is not a priority for the next two years.
- Mary Hall will depart as CFO in May 2026, and Phil Platt has been appointed as the incoming CFO.
Dec 8, 2025, 2:00 PM
Ingevity announces strategic portfolio update and CFO transition
NGVT
CFO Change
M&A
Share Buyback
- Mary Hall will depart as CFO in May 2026, and Phil Platt has been appointed as the incoming CFO.
- Ingevity is selling its Industrial Specialties business (expected to close by early 2026) and has initiated sales processes for its Advanced Polymer Technologies and Road Markings businesses to focus on core competencies.
- The "New Ingevity" will be built around two segments, Performance Materials (a $600 million business with 50%+ EBITDA margins) and Pavement Technologies (a $300 million business with mid-to-high teens margins), aiming for a pro forma revenue of around $900 million and 37% EBITDA margins.
- The company expects to generate nearly $1 billion in deployable cash over the next two years, prioritizing organic growth, debt reduction, and a minimum of $300 million in share repurchases, with the majority of remaining cash going towards debt paydown. This strategy is expected to drive double-digit EPS growth over the next few years.
Dec 8, 2025, 2:00 PM
Ingevity Announces CFO Transition, Strategic Portfolio Transformation, and Financial Outlook
NGVT
CFO Change
M&A
Guidance Update
Share Buyback
- Ingevity announced a CFO transition, with Mary Hall departing in May 2026 and Phil Platt taking over the role.
- The company is undergoing a portfolio transformation, with the sale of Industrial Specialties on track to close by early 2026, and new sales processes initiated for Advanced Polymer Technologies and Road Markings.
- The "new Ingevity" will focus on two core segments: Performance Materials and Pavement Technologies, aiming for a more focused, less volatile, and more profitable portfolio.
- Over the next two years, Ingevity expects to generate nearly $1 billion in deployable cash, which will be used for debt reduction (targeting 2-2.5 times leverage) and returning capital to shareholders, including utilizing its remaining $300 million share repurchase authorization. The company targets annual revenue and EBITDA growth of over 3% and annual EPS growth above 10%.
Dec 8, 2025, 2:00 PM
Ingevity Announces Strategic Alternatives for APT Segment and Road Markings Business
NGVT
M&A
Share Buyback
- Ingevity Corporation has completed its portfolio review and is exploring strategic alternatives, including potential sales, for its Advanced Polymer Technologies (APT) segment and Performance Chemicals Road Markings business.
- The company stated these actions are intended to enhance its portfolio, focusing on core businesses with best-in-class margins and cash flow generation, and to maximize shareholder value.
- As of December 8, 2025, Ingevity has completed over $30 million in stock repurchases during the fourth quarter of 2025 as part of its efforts to return capital to stockholders.
Dec 8, 2025, 11:54 AM
Ingevity Announces Divestiture and Recasts Financials for Discontinued Operations
NGVT
M&A
Accounting Changes
- Ingevity Corporation has entered into an Asset Purchase Agreement to sell its industrial specialties product line and North Charleston crude tall oil refinery, with the transaction expected to close by early 2026.
- The divested assets have been classified as discontinued operations, leading to a retrospective recasting of financial results for all periods presented, including FY 2023, FY 2024, and Q1, Q2, Q3 2025.
- For the third quarter of 2025, Ingevity reported Net sales from continuing operations of $333.1 million, Net income from continuing operations of $40.8 million, and Diluted earnings per share from continuing operations of $1.10.
- Additionally, Adjusted EBITDA from continuing operations for Q3 2025 was $110.4 million, with an Adjusted EBITDA Margin from continuing operations of 33.1%.
Dec 1, 2025, 9:58 PM
Ingevity and CHASM Expand Partnership for EV Battery Materials Supply Chain
NGVT
New Projects/Investments
- Ingevity Corporation has signed a license agreement with CHASM Advanced Materials, Inc. for CHASM's patented carbon nanotube (CNT) production technology.
- This agreement grants Ingevity the rights to manufacture NTeC®-E CNT conductive additives for battery applications in North America and select European countries.
- The partnership aims to establish secure, local supply chains for high-performance battery materials, supporting the rapidly expanding EV gigafactory ecosystem.
- This collaboration builds upon a joint development agreement signed in February 2024, which validated the superior performance of CHASM's NTeC®-E CNT in battery applications.
Nov 11, 2025, 12:26 PM
NGVT Reports Strong Q3 2025 Financial Results and Strategic Divestiture
NGVT
Earnings
M&A
Share Buyback
- NGVT reported strong Q3 2025 financial results, with Total Adjusted EBITDA increasing 13.9% to $121.2 million and Total Diluted Adjusted EPS rising 38.2% to $1.52, contributing to a 33.5% Total Adjusted EBITDA margin.
- The company announced the sale of its North Charleston crude tall oil refinery and the majority of the Industrial Specialties product line for $110 million, which are now reported as discontinued operations beginning in Q3 2025.
- NGVT generated $118 million in free cash flow in Q3 2025, enabling an accelerated net leverage improvement to 2.7x and $25 million in share repurchases.
Nov 6, 2025, 3:00 PM
Ingevity Reports Strong Q3 2025 Results, Announces Divestiture, and Updates Full-Year Guidance
NGVT
Earnings
M&A
Guidance Update
- In Q3 2025, Ingevity reported total company sales of $362 million, with adjusted EBITDA increasing by almost 500 basis points to $56.3 million, driving an adjusted EBITDA margin of 33.5%. This marks the sixth consecutive quarter of year-over-year adjusted EBITDA margin expansion.
- The company announced the sale of its industrial specialties business for $110 million, with the transaction expected to close in early 2026, and the majority of proceeds likely to be used for debt reduction. This business is now reported as discontinued operations.
- Ingevity ended Q3 2025 with net leverage of 2.7 times, already surpassing its previous year-end target of 2.8 times, and now expects net leverage to be approximately 2.6 times by year-end. The company also repurchased $25 million of shares in the quarter.
- The full-year outlook was adjusted to narrow the top end of the sales and EBITDA range due to ongoing tariff uncertainty and slower industrial demand, primarily impacting the APT segment. Performance Materials revenue is expected to be flat to slightly down year-over-year with EBITDA margins over 50%, while APT full-year revenue is projected to be down by mid-teens with EBITDA margins of 15-20%.
Nov 6, 2025, 3:00 PM
Quarterly earnings call transcripts for Ingevity.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more